Fabienne Ory‐Magne

5.2k total citations
49 papers, 1.2k citations indexed

About

Fabienne Ory‐Magne is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Fabienne Ory‐Magne has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Neurology, 9 papers in Cellular and Molecular Neuroscience and 9 papers in Physiology. Recurrent topics in Fabienne Ory‐Magne's work include Parkinson's Disease Mechanisms and Treatments (33 papers), Neurological disorders and treatments (19 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). Fabienne Ory‐Magne is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (33 papers), Neurological disorders and treatments (19 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). Fabienne Ory‐Magne collaborates with scholars based in France, New Zealand and Italy. Fabienne Ory‐Magne's co-authors include Christine Brefel‐Courbon, Olivier Rascol, Claire Thalamas, M. Simonetta‐Moreau, A. Gerdelat-Mas, Tarik Slaoui, Pierre Payoux, Estelle Dellapina, Monique Galitzky and François Tison and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Fabienne Ory‐Magne

43 papers receiving 1.2k citations

Peers

Countries citing papers authored by Fabienne Ory‐Magne

Since Specialization

Citations

This map shows the geographic impact of Fabienne Ory‐Magne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabienne Ory‐Magne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabienne Ory‐Magne more than expected).

Fields of papers citing papers by Fabienne Ory‐Magne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabienne Ory‐Magne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabienne Ory‐Magne. The network helps show where Fabienne Ory‐Magne may publish in the future.

Co-authorship network of co-authors of Fabienne Ory‐Magne

This figure shows the co-authorship network connecting the top 25 collaborators of Fabienne Ory‐Magne. A scholar is included among the top collaborators of Fabienne Ory‐Magne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabienne Ory‐Magne. Fabienne Ory‐Magne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS ‐Park Cohort 2025 ·Movement Disorders Clinical Practice ·(unknown), Paulo Bastos, (unknown), Christine Brefel‐Courbon, Isabelle Bénatru, Caroline Giordana, Anne Doé de Maindreville, Giovanni Castelnovo, (unknown), Luc Defebvre, Claire Thiriez, Stéphane Prange, Jean‐Luc Houéto, (unknown), Fabienne Ory‐Magne, (unknown), Nathalie Bertille, Jean‐Christophe Corvol, Olivier Rascol, Margherita Fabbri, (unknown)	2
2	Survey on Parkinson’s Disease Diagnosis Impact: Patients, Caregivers and Health Care Professionals’ Perspectives 2024 ·Journal of Clinical Medicine ·(unknown), Margherita Fabbri, Anne Doé de Maindreville, Alexandra Foubert‐Samier, (unknown), Nicolas Carrière, (unknown), (unknown), (unknown), Angélique Gerdelat, Guillaume Baille, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Frédérique Fluchère, Fabienne Ory‐Magne	0
3	How to distinguish spinocerebellar ataxia 27B from late onset cerebellar ataxia: insights from a case–control study 2024 ·Journal of Neurology ·(unknown), (unknown), Paulo Bastos, (unknown), Anne Pavy‐Le Traon, (unknown), Fabrice Bonneville, M. Renaud, Céline Bonnet, (unknown), Virginie Roth, Olivier Rascol, Fabienne Ory‐Magne, Margherita Fabbri	3
4	Subthalamic and nigral stimulation for freezing of gait in Parkinson's disease: Randomized pilot trial 2024 ·Journal of Parkinson s Disease ·Carlo Alberto Artusi, (unknown), Silvia Gallo, Domiziana Rinaldi, C. Campisi, Vanessa Rousseau, Claire Thalamas, Raquel Barbosa, Fabienne Ory‐Magne, Christine Brefel‐Courbon, Olivier Rascol, (unknown), (unknown), Maurizio Zibetti, Mario Giorgio Rizzone, Alberto Romagnolo, Gabriele Imbalzano, Leonardo Lopiano, Jean Luc Houeto, Margherita Fabbri	0
5	UMSARS Versus Laryngoscopy‐Based Assessment of Dysphagia 2023 ·Movement Disorders Clinical Practice ·(unknown), Anne Pavy‐Le Traon, (unknown), Olivier Rascol, Wassilios G. Meissner, (unknown), (unknown), (unknown), Fabienne Ory‐Magne, Virginie Woisard, Margherita Fabbri	1
6	Cerebrospinal fluid YKL‐40 level evolution is associated with autoimmune encephalitis remission 2023 ·Clinical & Translational Immunology ·(unknown), Marie Bénaiteau, Jérémie Pariente, Fabienne Ory‐Magne, Emmanuel Cheuret, Marie Rafiq, Wesley H. Brooks, Bénédicte Puissant‐Lubrano, Françoise Fortenfant, Yves Renaudineau, Chloé Bost	2
7	Challenging diagnosis and treatment decision of a long-history autoantibody-negative autoimmune encephalitis 2022 ·Parkinsonism & Related Disorders ·(unknown), (unknown), Chloé Bost, Françoise Fortenfant, M. Simonetta‐Moreau, Jérémie Pariente, Marie Rafiq, Christine Brefel‐Courbon, Olivier Rascol, Margherita Fabbri, Fabienne Ory‐Magne	1
8	A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study 2021 ·Parkinsonism & Related Disorders ·Margherita Fabbri, (unknown), Guillaume Baille, Matthieu Béreau, Christine Brefel Courbon, Giovanni Castelnovo, Nicolas Carrière, Philippe Damier, Luc Defebvre, Anne Doé de Maindreville, Frédérique Fluchère, (unknown), David Grabli, David Maltête, Vanessa Rousseau, (unknown), Claire Thalamas, Claire Thiriez, Olivier Rascol, Fabienne Ory‐Magne	19
9	Natural History of Adult Patients with GM2 Gangliosidosis 2020 ·Annals of Neurology ·Marion Masingue, (unknown), Timothée Lenglet, (unknown), Cyril Goizet, Xavier Ayrignac, Fabienne Ory‐Magne, (unknown), Foudil Lamari, (unknown), Catherine Caillaud, Yann Nadjar	41
10	Parkinson’s patients can rely on perspective cues to perceive 3D space 2017 ·Brain Research ·Alexandra Séverac Cauquil, Fabienne Ory‐Magne, (unknown), Monique Galitzky, (unknown), Christine Brefel‐Courbon, Simona Celebrini	3
11	Combined cardiovascular and sweating autonomic testing to differentiate multiple system atrophy from Parkinson's disease 2017 ·Neurophysiologie Clinique ·Anne Pavy‐Le Traon, Christine Brefel‐Courbon, (unknown), Fabienne Ory‐Magne, Olivier Rascol, Jean‐Michel Sénard	16
12	Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease 2014 ·Parkinsonism & Related Disorders ·(unknown), Fabienne Ory‐Magne, Cindy Canivet, M. Simonetta‐Moreau, Jean-Albert Lotterie, (unknown), Christophe Arbus, Angélique Gerdelat, Patrick Chaynes, Christine Brefel‐Courbon	42
13	Burden of L-Dopa-Induced Dyskinesia in Parkinson’s Disease Patients (PD-LID) in France – the Lidia Study Economic Analysis (Levodopa Induced Dyskinesia Impact Evaluation) 2013 ·Value in Health ·(unknown), François Viallet, Christine Brefel‐Courbon, Franck Durif, Fabienne Ory‐Magne, François Tison, I. Bourdeix, K. Rérat, (unknown)	2
14	Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease 2013 ·Parkinsonism & Related Disorders ·Christine Brefel‐Courbon, Fabienne Ory‐Magne, Claire Thalamas, Pierre Payoux, Olivier Rascol	66
15	The Unified Multiple System Atrophy Rating Scale: Intrarater reliability 2012 ·Movement Disorders ·Florian Krismer, Klaus Seppi, François Tison, Cristina Sampaio, (unknown), Cecilia Peralta, F. Yekhlef, Imad Ghorayeb, Fabienne Ory‐Magne, Monique Galitzky, Maria Bozi, (unknown), Carlo Colosimo, Felix Geser, Olivier Rascol, Werner Poewe, Niall Quinn, Gregor K. Wenning, (unknown)	11
16	Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson’s disease 2010 ·Clinical Neurophysiology ·Véronique Marchand‐Pauvert, A. Gerdelat-Mas, Fabienne Ory‐Magne, Fabienne Calvas, D. Mazevet, Sabine Meunier, Christine Brefel‐Courbon, Marie Vidailhet, M. Simonetta‐Moreau	12
17	Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study 2010 ·Movement Disorders ·Estelle Dellapina, A. Gerdelat-Mas, Fabienne Ory‐Magne, Laure Pourcel, Monique Galitzky, Fabienne Calvas, M. Simonetta‐Moreau, Claire Thalamas, Pierre Payoux, Christine Brefel‐Courbon	70
18	Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498‐499InsTC) 2009 ·Movement Disorders ·Fabienne Ory‐Magne, Christine Brefel‐Courbon, Pierre Payoux, Sabrina Debruxelles, Igor Sibon, Cyril Goizet, Pierre Labauge, Patrice Ménégon, Emmanuelle Uro‐Coste, Bernardino Ghetti, (unknown), Rubén Vidal, Olivier Rascol	17
19	Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study 2007 ·Journal of Neurology Neurosurgery & Psychiatry ·A. Gerdelat-Mas, M. Simonetta‐Moreau, Claire Thalamas, Fabienne Ory‐Magne, Tarik Slaoui, Olivier Rascol, Christine Brefel‐Courbon	179
20	Does ageing influence deep brain stimulation outcomes in Parkinson's disease? 2007 ·Movement Disorders ·Fabienne Ory‐Magne, Christine Brefel‐Courbon, M. Simonetta‐Moreau, Nelly Fabre, (unknown), Patrick Chaynes, I. Berry, Y Lazorthes, Olivier Rascol	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact